Leinco Technologies, Inc.'s Anti-Human CD279 (PD-1) (Nivolumab) - Custom monoclonal antibody. The Anti-Human CD279 (PD-1) (Nivolumab) - Custom Antibody was generated using PDCD1 as the antigen. It reacts with Homo Sapiens, Human, and Non-Human Primate. This antibody has been shown to work in applications such as: Blotting, Flow Cytometry, Functional Assay, and Immunohistochemistry.